Back to search

Shiitake, Hua Gu · 2017 · Case Reports

Low relevance

Flagellate Dermatitis in a Child Most Likely Secondary to Doxorubicin.

Lentinula edodes

Immune supportGut & microbiome
SpeciesShiitake, Hua Gu
JournalPediatric dermatology
Year2017

Key points

  • Flagellate dermatitis, a cutaneous eruption in which the patient appears to have been whipped, has been described with antineoplastic agents and shiitake mushroom ingestion
  • A 15-year-old girl with metastatic Ewing sarcoma developed pruritic erythematous linear lesions on her trunk that became hyperpigmented over time during her first cycle of chemotherapy with doxorubicin, vincristine, cyclophosphamide, and ganitumab
  • Flagellate dermatitis was diagnosed based on clinical and histologic findings
  • Flagellate dermatitis (FD) is a rare cutaneous eruption named for its appearance, in which the patient appears to have been whipped
  • It has been associated with chemotherapeutic agents such as bleomycin
  • We report FD in a child that occurred during chemotherapy treatment that included doxorubicin

Metadata-grounded summary

Citation abstract

Flagellate dermatitis, a cutaneous eruption in which the patient appears to have been whipped, has been described with antineoplastic agents and shiitake mushroom ingestion. A 15-year-old girl with metastatic Ewing sarcoma developed pruritic erythematous linear lesions on her trunk that became hyperpigmented over time during her first cycle of chemotherapy with doxorubicin, vincristine, cyclophosphamide, and ganitumab. Flagellate dermatitis was diagnosed based on clinical and histologic findings. Flagellate dermatitis (FD) is a rare cutaneous eruption named for its appearance, in which the patient appears to have been whipped. It has been associated with chemotherapeutic agents such as bleomycin. We report FD in a child that occurred during chemotherapy treatment that included doxorubicin.

Citation

Lim D, Aussedat M, Maillet-Lebel N, Marcoux D (2017). Flagellate Dermatitis in a Child Most Likely Secondary to Doxorubicin. Pediatric dermatology https://doi.org/10.1111/pde.13234 PMID: 28804924

Open citation